Evidence map›Paper›PMID 42143045›Full record

ArticleCell death & disease2026

PIKfyve preserves endolysosomal function in photoreceptors and RPE cells to maintain retinal integrity.

Ammaji Rajala, Larissa J Trevino, Thamaraiselvi Saravanan, Tyler M Black, Mohd A Bhat, Tuan Ngo, Mark Eminhizer, Jianhai Du, Visvanathan Ramamurthy, Raju V S Rajala

Abstract read
In one paragraph

Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ammaji RajalaDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-2108-8916
Larissa J TrevinoDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Thamaraiselvi SaravananDepartment of Biochemistry and Molecular Medicine, West Virginia University Health Sciences, Morgantown, WV, USA.
Tyler M BlackDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Mohd A BhatDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.ORCID http://orcid.org/0000-0002-2637-9157
Tuan NgoDepartment of Biochemistry and Molecular Medicine, West Virginia University Health Sciences, Morgantown, WV, USA.
Mark EminhizerDepartment of Biochemistry and Molecular Medicine, West Virginia University Health Sciences, Morgantown, WV, USA.ORCID http://orcid.org/0009-0007-2696-0930
Jianhai DuDepartment of Biochemistry and Molecular Medicine, West Virginia University Health Sciences, Morgantown, WV, USA.
Visvanathan RamamurthyDepartment of Biochemistry and Molecular Medicine, West Virginia University Health Sciences, Morgantown, WV, USA.
Raju V S RajalaDepartment of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. raju-rajala@ouhsc.edu.ORCID http://orcid.org/0000-0003-3783-8504

Funding

SECOND MESSENGERS IN THE RETINAR01EY000871 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI RAJALA, RAJU VS · 1985 to 2020
$7.2M
Retinal Mitochondrial Metabolism in Alzheimer's DiseaseR01EY031324 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2024
$2.0M
Proline metabolism in retinal healthR01EY032462 · NEI · WEST VIRGINIA UNIVERSITY · PI DU, JIANHAI · 2021 to 2025
$1.9M
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and DiseaseR01EY035282 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Raju VS Rajala · 2023 to 2026
$1.7M
NEI NIH HHS R01 EY000871NEI NIH HHS R01 EY031324NEI NIH HHS R01 EY032462NEI NIH HHS R01 EY035282U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) EY000871U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) EY031324U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) EY032462U.S. Department of Health & Human Services | NIH | National Eye Institute (NEI) EY035282
6 · The paper itself

Abstract

Photoreceptors rely on efficient clearance of outer segment material and mislocalized proteins to maintain cellular health and visual function. While retinal pigment epithelial (RPE) cells remove shed outer segment tips through daily phagocytosis, the mechanisms by which photoreceptors eliminate misfolded or mistargeted proteins are not well understood. Here, we identify PIKfyve, a lipid kinase that synthesizes phosphatidylinositol 3,5-bisphosphate [PI(3,5)P₂], as a key regulator of degradative and metabolic pathways in the retina. PIKfyve is highly expressed in rod photoreceptors, and its selective deletion causes progressive retinal degeneration marked by vacuolation, increased lysosomal markers, loss of outer nuclear layer thickness, and decline of rod and cone function. Partial or complete reduction of PIKfyve further accelerates degeneration in P23H rhodopsin mutant mice. In the RPE, PIKfyve deficiency disrupts phagocytosis and autophagy, leading to the accumulation of rhodopsin, lysosomal proteins, and lipid droplets, accompanied by metabolic imbalance. These results demonstrate that PIKfyve is essential for maintaining photoreceptor and RPE integrity by supporting lysosomal function, protein turnover, and metabolic stability, and suggest that enhancing PIKfyve activity may offer therapeutic potential for retinal degenerative diseases. This study is timely, as pharmacological inhibition of PIKfyve with apilimod-currently under clinical investigation for autoimmune, neurodegenerative, and infectious diseases-raises significant safety concerns, including lysosomal swelling, vacuolization, and impaired protein degradation, which could ultimately compromise retinal homeostasis and vision.

Indexed as

EndosomesLysosomesPhosphatidylinositol 3-KinasesRetinal Pigment EpitheliumRetinal Rod Photoreceptor CellsAnimalsAutophagyHumansMicePhagocytosisRetinal DegenerationRhodopsinPhosphatidylinositol 3-KinasesPikfyve protein, mouseRhodopsin

Identifiers

PMID42143045
PMCPMC13522625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.